<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Open Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Open Biol</journal-id>
<journal-id journal-id-type="publisher-id">RSOB</journal-id>
<journal-id journal-id-type="hwp">royopenbio</journal-id>
<journal-title-group>
<journal-title>Open Biology</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-2441</issn>
<publisher>
<publisher-name>The Royal Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29794032</article-id>
<article-id pub-id-type="pmc">5990648</article-id>
<article-id pub-id-type="doi">10.1098/rsob.180017</article-id>
<article-id pub-id-type="publisher-id">rsob180017</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>15</subject>
<subject>22</subject>
<subject>197</subject>
<subject>199</subject>
<subject>33</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="leader">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sequence analysis and structure prediction of ABHD16A and the roles of the ABHD family members in human disease</article-title>
<alt-title alt-title-type="short">A review</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-9255-0434</contrib-id>
<name>
<surname>Xu</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gu</surname>
<given-names>Weizhen</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ji</surname>
<given-names>Kai</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Zhao</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Haihua</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Wenming</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>College of Life Sciences, Henan Agricultural University</institution>, <addr-line>95 Wenhua Road, Zhengzhou 450002</addr-line>, <country>People's Republic of China</country></aff>
<aff id="af2"><label>2</label><institution>Henan Business Research Institute Co. Ltd</institution>, <addr-line>Zhengzhou, He'nan</addr-line>, <country>People's Republic of China</country></aff>
<author-notes>
<corresp id="cor1">e-mail: <email>xujun0828@126.com</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>5</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>8</volume>
<issue>5</issue>
<elocation-id>180017</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>4</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 The Authors.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>Published by the Royal Society under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits unrestricted use, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="rsob-8-180017.pdf"></self-uri>
<self-uri content-type="reviewer_comments" xlink:href="rsob180017_review_history.pdf"></self-uri>
<self-uri xlink:href="rsob180017.thumb.gif" xlink:role="icon"></self-uri>
<abstract>
<p>Abhydrolase domain containing 16A (ABHD16A) is a member of the α/β hydrolase domain-containing (ABHD) protein family and is expressed in a variety of animal cells. Studies have shown that ABHD16A has acylglycerol lipase and phosphatidylserine lipase activities. Its gene location in the main histocompatibility complex (MHC) III gene cluster suggests that this protein may participate in the immunomodulation of the body. The results of studies investigating nearly 20 species of ABHDs reveal that the ABHD proteins are key factors in metabolic regulation and disease occurrence and development. In this paper, we summarize the related progress regarding the function of ABHD16A and other ABHD proteins. A prediction of the active sites and structural domains of ABHD16A and an analysis of the amino acid sites are included. Moreover, we analysed the amino acid sequences of the ABHD16A molecules in different species and provide an overview of the related functions and diseases associated with these proteins. The functions and diseases related to ABHD are systematically summarized and highlighted. Future research directions for studies investigating the functions and mechanisms of these proteins are also suggested. Further studies investigating the function of ABHD proteins may further confirm their positions as important determinants of lipid metabolism and related diseases.</p>
</abstract>
<kwd-group>
<kwd>ABHD16A</kwd>
<kwd>ABHDs</kwd>
<kwd>metabolic disease</kwd>
<kwd>lipase</kwd>
<kwd>immune regulation</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>the Preferred Foundation for Returned Scholar from Overseas of Ministry of Human Resources and Social Security of China (Study abroad personnel and expert service center of Henan Province)</institution>
</institution-wrap>
</funding-source>
<award-id>2017-2</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>May 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<label>1.</label>
<title>Introduction</title>
<p>Human adhydrolase domain containing 16A (ABHD16A) is a 63 kDa protein containing 558 amino acid residues that is expressed in cells in multiple species. ABHD16A is a serine metabolism enzyme that typically contains an α/β hydrolase domain. Recently, studies have shown that ABHD16A is associated with neurodegenerative disease [<xref ref-type="bibr" rid="RSOB180017C1">1</xref>], immunoregulation [<xref ref-type="bibr" rid="RSOB180017C2">2</xref>], Kawasaki disease and coronary artery aneurysm [<xref ref-type="bibr" rid="RSOB180017C3">3</xref>]. Human ABHD16A is also known as human leucocyte antigen B (HLA-B) associated transcript 5 (BAT5). Because of its conserved features, ABHD was first identified in 1992 [<xref ref-type="bibr" rid="RSOB180017C4">4</xref>] and considered among the most diverse and widespread protein families, including esterases, proteases, lipases, peroxidases, epoxide hydrolases and dehalogenases [<xref ref-type="bibr" rid="RSOB180017C5">5</xref>]. Mammalian ABHDs, which are hydrolases, participate in lipid metabolism, intracellular signalling transduction and metabolic disorders [<xref ref-type="bibr" rid="RSOB180017C6">6</xref>]. Particularly within the prior 2–3 years, several groups have reported that ABHD2 [<xref ref-type="bibr" rid="RSOB180017C7">7</xref>], ABHD6 [<xref ref-type="bibr" rid="RSOB180017C8">8</xref>], ABHD12 [<xref ref-type="bibr" rid="RSOB180017C9">9</xref>], ABHD16 [<xref ref-type="bibr" rid="RSOB180017C2">2</xref>] and ABHD17 [<xref ref-type="bibr" rid="RSOB180017C10">10</xref>] could function in inflammation regulation and cancer pathogenesis. Although functional studies investigating the ABHDs are limited and the field is in its infancy, the growing awareness of the biological significance of the ABHDs has stimulated research in this field. Here, we discuss the current research state of ABHD16A, including its gene location and related functions. We also analysed the amino acid sequences and constructed a phylogeny tree of ABHD16A. The functions of other ABHD proteins are systematically summarized and discussed. Significant insights and future developments are also proposed.</p>
</sec>
<sec id="s2">
<label>2.</label>
<title>Gene location of ABHD16A</title>
<p>Human ABHD16A is located on chromosome 6p21.33. This gene has 21 exons and four different transcripts, two of which encode proteins (NM_001177515.1 and NM_021160.2), while the other two transcripts encode long non-coding RNAs (NR_033488.1 and NR_033489.1). The <italic>Abhd16a</italic> and <italic>bat2-bat5</italic> genes are closely associated with tumour necrosis factor (TNF) and the complement gene cluster C2 genes (<xref ref-type="fig" rid="RSOB180017F1">figure 1</xref><italic>a</italic>,<italic>b</italic>), and are located within the human major histocompatibility complex class III (MHC III) region [<xref ref-type="bibr" rid="RSOB180017C11">11</xref>–<xref ref-type="bibr" rid="RSOB180017C13">13</xref>]. Homoplastically, the mouse ABHD16A gene is located between TNF and Heat shock protein 70 (HSP70) near the Ck2b protein kinase gene (<xref ref-type="fig" rid="RSOB180017F1">figure 1</xref><italic>c</italic>) in the cluster of MHC III [<xref ref-type="bibr" rid="RSOB180017C13">13</xref>–<xref ref-type="bibr" rid="RSOB180017C15">15</xref>]. Owing to the position characteristics of the ABHD16A gene described above, the BAT1–BAT5 proteins have been predicted to be associated with some aspects of immunity.
<fig id="RSOB180017F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Position of the ABHD16A gene. Chromosome position of the human ABHD16A gene (<italic>a</italic>). ABHD16A is conserved in humans (<italic>b</italic>) and mice (<italic>c</italic>), and, together with other immunity-related genes, forms a gene cluster in the MHC III region. The coloured arrows indicate different genes and their transcriptional directions. The base pair numbers shown on the horizontal line indicate the distance between the genes.</p></caption><graphic xlink:href="rsob-8-180017-g1"></graphic></fig></p>
</sec>
<sec id="s3">
<label>3.</label>
<title>Protein structure of ABHD16A</title>
<p>We submitted the amino acid sequence of human ABHD16A to the Phyre2 portal to predict its three-dimensional protein structure (<xref ref-type="fig" rid="RSOB180017F2">figure 2</xref><italic>a</italic>) and transmembrane region (<xref ref-type="fig" rid="RSOB180017F2">figure 2</xref><italic>b</italic>). The results revealed four transmembrane regions: residues 59–85, 91–113, 204–229 and 350–365. The sequence alignment against the BLAST and Conserved Domains Database of NCBI revealed that ABHD16A has three conserved domains similar to Abhydrolase 1 (<xref ref-type="fig" rid="RSOB180017F2">figure 2</xref><italic>c</italic>), BioH (<xref ref-type="fig" rid="RSOB180017F2">figure 2</xref><italic>d</italic>) and PldB (Phospholipase D-orthologue B). The Abhydrolase 1 domain comprises amino acid residues 280 to 408. Many hydrolytic enzymes possess this catalytic domain. These enzymes conservatively preserve the catalytic residues, but not the binding sites, from their common ancestor [<xref ref-type="bibr" rid="RSOB180017C4">4</xref>]. BioH was identified as a biotin synthesis enzyme and was predicted to contribute to fatty acid synthesis because of its carboxylesterase activity in substrates with short acyl chains [<xref ref-type="bibr" rid="RSOB180017C16">16</xref>,<xref ref-type="bibr" rid="RSOB180017C17">17</xref>]. The BioH domain of ABHD16A is located in amino acids 276–428, but its precise function must be further investigated in greater detail. The PldB domain has a 3D structure similar to that of Abhydrolase 1, is located within amino acid residues 302–398 and exhibits lysophospholipase activity [<xref ref-type="bibr" rid="RSOB180017C18">18</xref>–<xref ref-type="bibr" rid="RSOB180017C20">20</xref>].
<fig id="RSOB180017F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Structural prediction of the human ABHD16A protein. (<italic>a</italic>) Three-dimensional patterns predicted by Phyre2. (<italic>b</italic>) Transmembrane region predicted by Phyre2. (<italic>c</italic>) Abhydrolase onefold prediction by the Conserved Domains Database of NCBI. (<italic>d</italic>) BioH domain predicted by the Conserved Domains Database of NCBI.</p></caption><graphic xlink:href="rsob-8-180017-g2"></graphic></fig></p>
<p>The predicted protein structure of ABHD16A is similar to that of other ABHDs. Approximately 23 different ABHD proteins belonging to the α/β-hydrolase-fold superfamily have been reported thus far. A typical α/β-hydrolase fold has 8 β-strands and 6 α-helices [<xref ref-type="bibr" rid="RSOB180017C6">6</xref>]. The hydrolytic enzyme active centre is formed by histidine residues and surrounded by helices and loops linking the β-strands. In most cases, Ser and occasionally Cys or Asp lie in a compact loop. In addition, a highly conserved histidine residue is present in a variable loop behind β8 [<xref ref-type="bibr" rid="RSOB180017C6">6</xref>].</p>
</sec>
<sec id="s4">
<label>4.</label>
<title>Conservation analysis of the amino acid sequence of ABHD16A</title>
<p>ABHD16A is a highly conserved protein in mammals that is expressed in cells in different tissues [<xref ref-type="bibr" rid="RSOB180017C19">19</xref>]. Using molecular evolutionary genetics analysis (MEGA) software, we analysed the amino acid sequences of ABHD16A in 13 mammalian species (<xref ref-type="table" rid="RSOB180017TB1">table 1</xref>). The results revealed 412 conserved sites, 146 variable sites, 58 parsimony-informative sites and 88 singleton sites. Both the maximum-likelihood phylogenetic analysis and sequence comparison showed that the ABHD16A protein sequences could be divided into three categories (<xref ref-type="fig" rid="RSOB180017F3">figure 3</xref><italic>a</italic>). The significant differences in the length of the ABHD16A polypeptide chain imply that variable splicing occurs during the post-transcriptional processing of ABHD16A mRNA. For example, human isoforms a and b of ABHD16A have 558 and 525 aa, respectively; Sikkim mice isoforms a and b have 558 and 339 aa, respectively. However, the functional domains, including the alpha/beta hydrolytic enzyme domain, acyltransferase motif HXXXXD (H, histidine; D, aspartic acid and X, any residues), lipase-like motifs GXSXXG (G, glycine; S, serine and X, any residues) and nucleophile centres (Ser, Cys or Asp), are highly conserved (<xref ref-type="fig" rid="RSOB180017F3">figure 3</xref><italic>b</italic>) [<xref ref-type="bibr" rid="RSOB180017C6">6</xref>]. The present analysis further confirmed the findings of previous reports [<xref ref-type="bibr" rid="RSOB180017C6">6</xref>,<xref ref-type="bibr" rid="RSOB180017C19">19</xref>] and that ABHD16A is genetically distant from the other members of the ABHD family [<xref ref-type="bibr" rid="RSOB180017C6">6</xref>].
<fig id="RSOB180017F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Conservation analysis of the amino acid sequence of ABHD16A. (<italic>a</italic>) Phylogenetic tree of the ABHD16A amino acid sequences from 13 mammalian species. Codes prefixed by X represent different variants. The phylogenetic tree was constructed using the neighbour-joining method by MEGA. (<italic>b</italic>) Multiple alignment of ABHD16A in 13 mammals using DNAMAN, and the different colours represent different homologies of amino acids. The amino acid residues in the red boxes indicate the predicted instructions of the lipase-like motif (GXSXXG), the conserved (HXXXXD) motif and the active nucleophile centre (#, Ser, Cys or Asp), respectively.</p></caption><graphic xlink:href="rsob-8-180017-g3"></graphic></fig>
<table-wrap id="RSOB180017TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>References of ABHD16A in 13 mammalian species.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">species</th><th align="left" colspan="1" rowspan="1">GenBank GI no.</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><italic>Homo sapiens</italic></td><td colspan="1" rowspan="1">NP_066983.1(isoform a), NP_001170986.1(isoform b)</td></tr><tr><td colspan="1" rowspan="1"><italic>Mus musculus</italic></td><td colspan="1" rowspan="1">NP_848707.1</td></tr><tr><td colspan="1" rowspan="1"><italic>Rattus norvegicus</italic></td><td colspan="1" rowspan="1">NP_997696.1</td></tr><tr><td colspan="1" rowspan="1"><italic>Pan troglodytes</italic></td><td colspan="1" rowspan="1">NP_001267411.1</td></tr><tr><td colspan="1" rowspan="1"><italic>Bos taurus</italic></td><td colspan="1" rowspan="1">NP_001069073.1</td></tr><tr><td colspan="1" rowspan="1"><italic>Microcebus murinus</italic></td><td colspan="1" rowspan="1">XP_012596454.1(isoform X1), XP_012596455.1(isoform X2), XP_012596456.1(isoform X3), XP_012596457.1(isoform X4)</td></tr><tr><td colspan="1" rowspan="1"><italic>Mus pahari</italic></td><td colspan="1" rowspan="1">XP_021073260.1(isoform X1), XP_021073262.1(isoform X2)</td></tr><tr><td colspan="1" rowspan="1"><italic>Castor canadensis</italic></td><td colspan="1" rowspan="1">XP_020032186.1(isoformX1), XP_020032188.1(isoform X2), XP_020032189.1(isoform X3)</td></tr><tr><td colspan="1" rowspan="1"><italic>Papio anubis</italic></td><td colspan="1" rowspan="1">XP_003897405.1(isoform X1), XP_009203089.1(isoform X2), XP_021792374.1(isoform X3)</td></tr><tr><td colspan="1" rowspan="1"><italic>Sus scrofa</italic></td><td colspan="1" rowspan="1">NP_001182255.1</td></tr><tr><td colspan="1" rowspan="1"><italic>Aotus nancymaae</italic></td><td colspan="1" rowspan="1">XP_012292099.1(isoform X1), XP_012292100.1(isoform X2)</td></tr><tr><td colspan="1" rowspan="1"><italic>Macaca fascicularis</italic></td><td colspan="1" rowspan="1">NP_001271025.1</td></tr><tr><td colspan="1" rowspan="1"><italic>Pongo abelii</italic></td><td colspan="1" rowspan="1">NP_001126487.1</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="s5">
<label>5.</label>
<title>Research progress related to ABHD16A</title>
<p>In 1989, Spies <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180017C12">12</xref>] predicted that ABHD16 probably functioned in immune regulation processes because its gene location is similar to that of TNF and HSP70 in the MHC III gene cluster [<xref ref-type="bibr" rid="RSOB180017C12">12</xref>,<xref ref-type="bibr" rid="RSOB180017C13">13</xref>]. However, during the following two decades, few gratifying results regarding ABHD16A were reported. Subsequently, Mathew's group reported that the expression of ABHD16A could influence the immunogenicity of bone marrow cells in recombinant B10.BR mice [<xref ref-type="bibr" rid="RSOB180017C21">21</xref>]. By analysing the polymorphisms and haplotypes of ABHD16A, Hsieh <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180017C3">3</xref>] found several associations between ABHD16A and the genetic predisposition to coronary artery aneurysm and Kawasaki disease. However, during the following few years, the underlying mechanism was not further explored.</p>
<p>In 2014, Savinainen <italic>et al</italic>. pioneered a study investigating the enzymatic characteristics of human ABHD16A <italic>in vitro</italic> and revealed that it was a lipase with preference for medium-chain and long-chain fatty acids, especially long-chain unsaturated monoglycerides and 15-deoxy-Δ12,14-prostaglandin J2–2-glycerol ester (15d-PGJ2-G) [<xref ref-type="bibr" rid="RSOB180017C19">19</xref>], and its esterase hydrolysis activity could effectively be inhibited by hormone-sensitive lipase inhibitors. Another important breakthrough was achieved by Kamat <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180017C2">2</xref>] who showed that the interplay between ABHD16A and ABHD12 dynamically regulates immunomodulatory lysophosphatidylserines (lyso-PSs) and consequently affects the release of lipopolysaccharide-induced proinflammatory cytokines from macrophages. A previous study showed that homozygous mutations of ABHD12 could cause autosomal recessive neurodegenerative disease characterized by polyneuropathy, hearing loss, ataxia, restenosis pigmentosa and cataract (PHARC) [<xref ref-type="bibr" rid="RSOB180017C22">22</xref>–<xref ref-type="bibr" rid="RSOB180017C24">24</xref>]. ABHD12 deficiency aggravated neuroinflammation and was closely associated with cerebellar atrophy and peripheral neuroinflammatory disease in cell models, murine PHARC and zebrafish [<xref ref-type="bibr" rid="RSOB180017C9">9</xref>,<xref ref-type="bibr" rid="RSOB180017C24">24</xref>]. ABHD16A has a higher specific activity with PS than with hydrolysing lysophospholipids, other diacylated phospholipids and neutral lipids [<xref ref-type="bibr" rid="RSOB180017C2">2</xref>]. Several selective inhibitors of ABHD16A have been identified through comparative activity-based protein profiling analyses [<xref ref-type="bibr" rid="RSOB180017C2">2</xref>,<xref ref-type="bibr" rid="RSOB180017C19">19</xref>]. In addition, a more recent study showed that ABHD16A is an immune-balancing regulator that catalyses the hydrolysis of prostaglandin-glycerol (PG-G) in neutrophils [<xref ref-type="bibr" rid="RSOB180017C1">1</xref>]. In <italic>Sus scrofa</italic>, a correlation was observed between single nucleotide polymorphisms (SNPs) of the ABHD16A gene and back fat thickness, implying that ABHD16A performs a function in the metabolism of adipose tissue [<xref ref-type="bibr" rid="RSOB180017C25">25</xref>].</p>
<p>Several interaction partners of ABHD16A, including IFITM1 (interferon-induced transmembrane proteins), hnRNP1 (heterogeneous nuclear ribonucleoprotein A1), RNF5 (RING zinc-finger domain protein), SPP (signal peptide peptidase), COX II (Mitochondrial cytochrome oxidase II), ATP5G3 (subunit of mitochondrial ATP synthase H<sup>+</sup> transporter) and NAD3 (Mitochondrial NADH dehydrogenase), were identified through a high-throughput yeast two-hybrid screening [<xref ref-type="bibr" rid="RSOB180017C26">26</xref>]. The functions of the interaction proteins above suggest that ABHD16A might play a role in multiple physiological processes. However, no further studies investigating the function or mechanism of these interactions have been reported. A microarray-based long non-coding RNA (lncRNA) expression profiling study showed that the lncRNA of ABHD16A could be a novel biomarker of coronary aneurysm [<xref ref-type="bibr" rid="RSOB180017C27">27</xref>]. In activated B cells, the reduced mRNA expression of ABHD16A by MiR-155 provided a clue regarding ABHD16A functions based on the important role played by mic-155 in various physiological and pathological processes [<xref ref-type="bibr" rid="RSOB180017C28">28</xref>]. Our latest studies showed that ABHD16A inhibited the application of Japanese encephalitis virus <italic>in vitro</italic> and was associated with the risk of inflammation-related liver disease (JX 2018 unpublished data).</p>
</sec>
<sec id="s6">
<label>6.</label>
<title>Research progress related to the ABHD family members</title>
<p>Different members of the ABHD family are located on different chromosomes. These proteins have different numbers of exons and amino acid residues and show expression differences in different tissues. Although the functions of several members are unknown, studies have shown that these proteins play significant roles in glucose and lipid metabolism, immunoregulation and many human diseases (<xref ref-type="table" rid="RSOB180017TB2">table 2</xref>).
<table-wrap id="RSOB180017TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Mammalian ABHD superfamily members. The data regarding the number of exons were obtained from BioGPS, and the data regarding the relatively high expression in normal human tissues were primarily obtained from the BioGPS portal and the reported references.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">protein name</th><th align="left" colspan="1" rowspan="1">molecular weight (kDa)</th><th align="left" colspan="1" rowspan="1">aliases</th><th align="left" colspan="1" rowspan="1">gene location in humans</th><th align="left" colspan="1" rowspan="1">number of exons</th><th align="left" colspan="1" rowspan="1">relatively high expression in normal human tissues (BioGPS)</th><th align="left" colspan="1" rowspan="1">related function or role in disease</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">ABHD1</td><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">LABH1</td><td colspan="1" rowspan="1">2p23.3</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">testis, sperm saphenous</td><td colspan="1" rowspan="1">related to oxidative stress in mouse and rat models [<xref ref-type="bibr" rid="RSOB180017C29">29</xref>–<xref ref-type="bibr" rid="RSOB180017C32">32</xref>]; expression downregulation is driven by hepatic steatosis and insulin resistance induced by Notch signalling [<xref ref-type="bibr" rid="RSOB180017C33">33</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD2</td><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1">HS1–2, LABH2, PHPS1–2</td><td colspan="1" rowspan="1">15q26.1</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">prostate, lung, NK cells, whole blood</td><td colspan="1" rowspan="1">a glyceridase and ester hydrolase cleaving 2AG and leading to sperm hyperactivation in a progesterone-dependent manner [<xref ref-type="bibr" rid="RSOB180017C34">34</xref>–<xref ref-type="bibr" rid="RSOB180017C36">36</xref>]; an androgen-regulated gene promoting prostate cancer growth and resistance to chemotherapy [<xref ref-type="bibr" rid="RSOB180017C37">37</xref>]; essential for the reproduction of HBV [<xref ref-type="bibr" rid="RSOB180017C38">38</xref>,<xref ref-type="bibr" rid="RSOB180017C39">39</xref>]; involved in calcium transfer from the endoplasmic reticulum to mitochondria [<xref ref-type="bibr" rid="RSOB180017C40">40</xref>] and chronic obstructive pulmonary disease (COPD) in a Chinese Han population [<xref ref-type="bibr" rid="RSOB180017C41">41</xref>]; associated with anoikis resistance in ovarian cancer [<xref ref-type="bibr" rid="RSOB180017C7">7</xref>] and possibly associated with tumorigenesis in hepatocytes, stomach cells and colon cells [<xref ref-type="bibr" rid="RSOB180017C42">42</xref>,<xref ref-type="bibr" rid="RSOB180017C43">43</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD3</td><td colspan="1" rowspan="1">46</td><td colspan="1" rowspan="1">LABH3</td><td colspan="1" rowspan="1">18q11.2</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">colon, small intestine, whole blood</td><td colspan="1" rowspan="1">a brain serine hydrolase related to the activation of the endocannabinoid system [<xref ref-type="bibr" rid="RSOB180017C44">44</xref>]; a lipase playing the role of a physiological regulator in the metabolism of medium-chain phospholipids [<xref ref-type="bibr" rid="RSOB180017C45">45</xref>]; possibly influences innate immunity by transcription factor T-bet [<xref ref-type="bibr" rid="RSOB180017C46">46</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD4</td><td colspan="1" rowspan="1">39</td><td colspan="1" rowspan="1">ABH4</td><td colspan="1" rowspan="1">14q11.2</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">adipocyte, testis</td><td colspan="1" rowspan="1">functions in <italic>N</italic>-Acyl ethanolamine synthesis as a (lyso) <italic>N</italic>-acyl phosphatidylethanolamine-selective lipase [<xref ref-type="bibr" rid="RSOB180017C47">47</xref>,<xref ref-type="bibr" rid="RSOB180017C48">48</xref>]; a novel regulator of anoikis resistance [<xref ref-type="bibr" rid="RSOB180017C49">49</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD5</td><td colspan="1" rowspan="1">39</td><td colspan="1" rowspan="1">CGI58; IECN2; NCIE2; CDS</td><td colspan="1" rowspan="1">3p21.33</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">adipose tissue, bone marrow</td><td colspan="1" rowspan="1">a critical acyltransferase with lysophosphatidylglycerol acyltransferase and adipose triglyceride lipase activities and is involved in metabolic disorders; as a lysophosphatidylglycerol acyltransferase, prompts autophagy and is associated with Chanarin-Dorfman syndrome by attenuating inflammatory responsiveness via the promotion of PPAR gamma signalling [<xref ref-type="bibr" rid="RSOB180017C50">50</xref>–<xref ref-type="bibr" rid="RSOB180017C52">52</xref>]; activates other adipose triglyceride lipases and stimulates triglyceride breakdown as an adipose triglyceride lipase [<xref ref-type="bibr" rid="RSOB180017C50">50</xref>,<xref ref-type="bibr" rid="RSOB180017C53">53</xref>,<xref ref-type="bibr" rid="RSOB180017C54">54</xref>]; a tumour suppressor in human colorectal carcinoma development and progression [<xref ref-type="bibr" rid="RSOB180017C55">55</xref>] and serves as a novel tumour marker in sebaceous carcinoma [<xref ref-type="bibr" rid="RSOB180017C56">56</xref>]; plays an important role in protecting against atherosclerosis development in macrophages in mice [<xref ref-type="bibr" rid="RSOB180017C57">57</xref>]; tissue-specific ABHD5 deficiency leads to lipid imbalance in the liver and plasma caused by the insufficient secretion of postprandial lipoprotein [<xref ref-type="bibr" rid="RSOB180017C58">58</xref>], and upregulates gene expression related to hepatic insulin resistance, neutral lipid storage disease, fibrosis, inflammation and hepatic steatosis [<xref ref-type="bibr" rid="RSOB180017C59">59</xref>–<xref ref-type="bibr" rid="RSOB180017C62">62</xref>]; downregulation of ABHD5 in the heart stimulates the development of diabetic cardiomyopathy by aggravating myocardial steatosis and oxidative stress [<xref ref-type="bibr" rid="RSOB180017C63">63</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD6</td><td colspan="1" rowspan="1">38</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">3p14.3</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">small intestine, spleen, duodenum</td><td colspan="1" rowspan="1">as a monoacylglycerol hydrolase, involved in the activation of the endocannabinoid signalling system [<xref ref-type="bibr" rid="RSOB180017C44">44</xref>,<xref ref-type="bibr" rid="RSOB180017C64">64</xref>–<xref ref-type="bibr" rid="RSOB180017C67">67</xref>] and systemic lupus erythematosus [<xref ref-type="bibr" rid="RSOB180017C68">68</xref>]; negatively regulates AMPAR-mediated synaptic transmission in hippocampal neurons in HEK293 T cells [<xref ref-type="bibr" rid="RSOB180017C69">69</xref>,<xref ref-type="bibr" rid="RSOB180017C70">70</xref>]; acts as a critical regulator of metabolic syndrome [<xref ref-type="bibr" rid="RSOB180017C71">71</xref>] and energy balance, including the functional realization of brown adipose and the browning of white fat by promoting glucose-stimulated insulin secretion [<xref ref-type="bibr" rid="RSOB180017C72">72</xref>]; participates in the pathogenesis of obesity and fatty liver due to its degradation functions in late endosomal/lysosomal lipid Bis [<xref ref-type="bibr" rid="RSOB180017C64">64</xref>]; a new potential diagnostic marker or an alternative therapeutic target in Ewing family tumours [<xref ref-type="bibr" rid="RSOB180017C73">73</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD7</td><td colspan="1" rowspan="1">42</td><td colspan="1" rowspan="1">EPHX4; EH4; EPHXRP</td><td colspan="1" rowspan="1">1p22.1</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">brain</td><td colspan="1" rowspan="1">a high-activity epoxide hydrolase for fatty acids [<xref ref-type="bibr" rid="RSOB180017C74">74</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD8</td><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">19p13.11</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">brain</td><td colspan="1" rowspan="1">underlying breast and ovarian cancer risk [<xref ref-type="bibr" rid="RSOB180017C75">75</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD9</td><td colspan="1" rowspan="1">41</td><td colspan="1" rowspan="1">EPHX3; EH3</td><td colspan="1" rowspan="1">19p13.12</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">skin, oesophagus</td><td colspan="1" rowspan="1">a high-activity epoxide hydrolase for fatty acids [<xref ref-type="bibr" rid="RSOB180017C74">74</xref>]; the promoter hypermethylation of ABHD9 possibly leads to prostate cancer recurrence and serves as a marker for prostate cancer prognosis [<xref ref-type="bibr" rid="RSOB180017C76">76</xref>,<xref ref-type="bibr" rid="RSOB180017C77">77</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD10</td><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">3q13.2</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">pineal, kidney, thyroid</td><td colspan="1" rowspan="1">affects the formation of immunotoxic metabolites, mycophenolic acid acyl-glucuronide [<xref ref-type="bibr" rid="RSOB180017C78">78</xref>,<xref ref-type="bibr" rid="RSOB180017C79">79</xref>]; acyl glucuronide and probenecid acyl glucuronide in human liver [<xref ref-type="bibr" rid="RSOB180017C80">80</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD11</td><td colspan="1" rowspan="1">35</td><td colspan="1" rowspan="1">PP1226; WBSCR21</td><td colspan="1" rowspan="1">7q11.23</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">colon, prostate</td><td colspan="1" rowspan="1">is associated with the development of distant metastases and serves as a novel biomarker of lung adenocarcinoma [<xref ref-type="bibr" rid="RSOB180017C81">81</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD12</td><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">PHARC; ABHD12A; BEM46L2; C20orf22; dJ965G21.2</td><td colspan="1" rowspan="1">20p11.21</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">thyroid, brain</td><td colspan="1" rowspan="1">participates in the breakdown of 2-AG in the central nervous system and along with MAGL and ABHD6, controls 99% of 2-AG hydrolysis in the brain [<xref ref-type="bibr" rid="RSOB180017C65">65</xref>,<xref ref-type="bibr" rid="RSOB180017C82">82</xref>]; serves as a lysophospholipase and metabolizes lysophosphatidylserine, which participates in the endocannabinoid signalling pathway [<xref ref-type="bibr" rid="RSOB180017C9">9</xref>,<xref ref-type="bibr" rid="RSOB180017C18">18</xref>]; associated with PHARC [<xref ref-type="bibr" rid="RSOB180017C9">9</xref>,<xref ref-type="bibr" rid="RSOB180017C22">22</xref>,<xref ref-type="bibr" rid="RSOB180017C23">23</xref>,<xref ref-type="bibr" rid="RSOB180017C83">83</xref>,<xref ref-type="bibr" rid="RSOB180017C84">84</xref>]; a potential indicator of liver diseases in plasma [<xref ref-type="bibr" rid="RSOB180017C12">12</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD12B</td><td colspan="1" rowspan="1">41</td><td colspan="1" rowspan="1">BEM46L3; C14orf29; c14_5314</td><td colspan="1" rowspan="1">14q22.1</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">skin</td><td colspan="1" rowspan="1">a gene potentially related to obesity [<xref ref-type="bibr" rid="RSOB180017C85">85</xref>], chronic periodontitis [<xref ref-type="bibr" rid="RSOB180017C86">86</xref>] and longitudinal changes in ventricle size [<xref ref-type="bibr" rid="RSOB180017C87">87</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD13</td><td colspan="1" rowspan="1">39</td><td colspan="1" rowspan="1">BEM46L1; C13orf6; bA153I24.2</td><td colspan="1" rowspan="1">13q33.3</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">bone marrow, thyroid</td><td colspan="1" rowspan="1">very little known</td></tr><tr><td colspan="1" rowspan="1">ABHD14A</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">DORZ1</td><td colspan="1" rowspan="1">3p21.2</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">kidney, thyroid, adrenal</td><td colspan="1" rowspan="1">a candidate gene for autism spectrum disorder [<xref ref-type="bibr" rid="RSOB180017C88">88</xref>]; plays a potential role in cerebellar development through Zic1, which is a finger protein that controls vertebrate neural development [<xref ref-type="bibr" rid="RSOB180017C89">89</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD14B</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">CIB; HEL-S-299</td><td colspan="1" rowspan="1">3p21.2</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">fat, kidney, liver</td><td colspan="1" rowspan="1">a potential structural distinctive cofactor with hydrolase activity for transcription initiation factor [<xref ref-type="bibr" rid="RSOB180017C90">90</xref>]; a marker of tumour progression in an unknown primary syndrome in neuroendocrine tumours [<xref ref-type="bibr" rid="RSOB180017C91">91</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD15</td><td colspan="1" rowspan="1">52</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">17q11.2</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">fat</td><td colspan="1" rowspan="1">is involved in insulin signalling in adipocytes [<xref ref-type="bibr" rid="RSOB180017C92">92</xref>–<xref ref-type="bibr" rid="RSOB180017C94">94</xref>]; Plays an important role in the development of adipocytes and apoptosis [<xref ref-type="bibr" rid="RSOB180017C95">95</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD16A</td><td colspan="1" rowspan="1">63</td><td colspan="1" rowspan="1">BAT5; NG26; PP199; D6S82E</td><td colspan="1" rowspan="1">6p21.33</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">testis, brain</td><td colspan="1" rowspan="1">refer to the fourth part of the text</td></tr><tr><td colspan="1" rowspan="1">ABHD16B</td><td colspan="1" rowspan="1">53</td><td colspan="1" rowspan="1">C20orf135; dJ591C20.1</td><td colspan="1" rowspan="1">20q13.33</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">testis</td><td colspan="1" rowspan="1">the methylation of the abhd16b gene was related to COPD [<xref ref-type="bibr" rid="RSOB180017C96">96</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD17A</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">C19orf27; FAM108A1</td><td colspan="1" rowspan="1">19p13.3</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">spleen, bone marrow</td><td colspan="1" rowspan="1">as a depalmitoylating enzyme, depalmitoylates Ras [<xref ref-type="bibr" rid="RSOB180017C97">97</xref>,<xref ref-type="bibr" rid="RSOB180017C98">98</xref>], PSD95 [<xref ref-type="bibr" rid="RSOB180017C10">10</xref>,<xref ref-type="bibr" rid="RSOB180017C98">98</xref>] and MAP6 [<xref ref-type="bibr" rid="RSOB180017C99">99</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD17B</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">CGI-67; C9orf77; FAM108B1</td><td colspan="1" rowspan="1">9q21.13</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">brain</td><td colspan="1" rowspan="1">a depalmitoylating enzyme [<xref ref-type="bibr" rid="RSOB180017C10">10</xref>,<xref ref-type="bibr" rid="RSOB180017C97">97</xref>–<xref ref-type="bibr" rid="RSOB180017C99">99</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD17C</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">FAM108C1</td><td colspan="1" rowspan="1">15q25.1</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">colon</td><td colspan="1" rowspan="1">a depalmitoylating enzyme [<xref ref-type="bibr" rid="RSOB180017C10">10</xref>,<xref ref-type="bibr" rid="RSOB180017C97">97</xref>–<xref ref-type="bibr" rid="RSOB180017C99">99</xref>]</td></tr><tr><td colspan="1" rowspan="1">ABHD18</td><td colspan="1" rowspan="1">46.9</td><td colspan="1" rowspan="1">C4orf29</td><td colspan="1" rowspan="1">4q28.2</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">ubiquitously expressed at low to moderate levels</td><td colspan="1" rowspan="1">very little is known about this protein; probably associated with human hepatocellular carcinoma (HCC) [<xref ref-type="bibr" rid="RSOB180017C100">100</xref>] and fatty acid composition in pig muscle [<xref ref-type="bibr" rid="RSOB180017C101">101</xref>]</td></tr></tbody></table></table-wrap></p>
<sec id="s6a">
<label>6.1.</label>
<title>Direct contribution to lipid metabolism</title>
<p>The biosynthesis and degradation of lipids are vital for organisms to sustain normal life activities, because lipids are important components of cellular structures, sources of energy, intracellular signalling molecules and are also involved in the acyl modification of proteins. The results showed that, in the ABHD protein family, ABHD2, ABHD3, ABHD4, ABHD5, ABHD6, ABHD12 and ABHD16 participated in the metabolism of glycerine esters or phospholipids. ABHD2 is a new triglyceride lipase with an ester hydrolysing capacity [<xref ref-type="bibr" rid="RSOB180017C34">34</xref>]. In addition, ABHD2 acted as a progesterone receptor associated with lipid hydrolase in the activation of sperm in the reproductive process [<xref ref-type="bibr" rid="RSOB180017C35">35</xref>]. ABHD3 selectively cleaved medium-chain phospholipids and oxidized short phospholipids [<xref ref-type="bibr" rid="RSOB180017C45">45</xref>]. In the mammalian nervous system, ABHD4 was a major regulator of <italic>N</italic>-acyl phospholipid metabolism, and had the capacity to hydrolyse <italic>N</italic>-arachidonoyl phosphatidylethanolamine nape, lyso-nape, <italic>N</italic>-acyl-phospholipid serine and other <italic>N</italic>-acyl phospholipids [<xref ref-type="bibr" rid="RSOB180017C47">47</xref>,<xref ref-type="bibr" rid="RSOB180017C48">48</xref>,<xref ref-type="bibr" rid="RSOB180017C102">102</xref>]. ABHD5 could promote the decomposition of triglyceride due to its fatty triglyceride lipase activity [<xref ref-type="bibr" rid="RSOB180017C50">50</xref>,<xref ref-type="bibr" rid="RSOB180017C53">53</xref>,<xref ref-type="bibr" rid="RSOB180017C54">54</xref>]. ABHD6, which is a monoacylglycerol hydrolase, functions in balancing energy, regulating the function of brown adipose and modulating white adipose browning [<xref ref-type="bibr" rid="RSOB180017C72">72</xref>]. Both ABHD6 and ABHD12, which are 2-arachidonylglycerol hydrolases, are involved in the endocannabinoid and eicosanoid signalling pathways in the brain [<xref ref-type="bibr" rid="RSOB180017C44">44</xref>]. A transcriptome analysis indicated that ABHD18A was probably related to the modulation of fatty acid composition in pig muscle [<xref ref-type="bibr" rid="RSOB180017C101">101</xref>].</p>
</sec>
<sec id="s6b">
<label>6.2.</label>
<title>An important role in liver diseases</title>
<p>The liver is the largest digestive gland and the centre of material and energy metabolism in the human body. As lipases, the ABHD proteins exert significant effects on hepatic glucose and lipid metabolism. The results of one study [<xref ref-type="bibr" rid="RSOB180017C59">59</xref>] showed that several members of the ABHD family were related to the occurrence and development of hepatopathy. Liver-specific ABHD5 knockout mice exhibit hepatomegaly and steatosis, and with increasing age the expression of inflammation factors and fibrosis factors at the mRNA level were significantly increased. These results suggest that the deletion of ABHD5 in the liver not only directly leads to liver steatosis but is also involved in steatohepatitis and fibrosis. The mice treated with the ABHD5 antisense oligonucleotide showed severe hepatic steatosis and increased hepatocellular diacylglycerol (DAG), which is a well-documented trigger of insulin resistance, but unexpectedly remained insulin-sensitive [<xref ref-type="bibr" rid="RSOB180017C61">61</xref>]. The molecular mechanism could be that a reduction in ABHD5 promotes the isolation of hepatocellular DAG in the lipid droplet/ER section and that the DAG redistribution from the plasma membrane precludes the PKCɛ translocation to the plasma membrane, which leads to liver insulin resistance [<xref ref-type="bibr" rid="RSOB180017C61">61</xref>,<xref ref-type="bibr" rid="RSOB180017C63">63</xref>]. ABHD18 was identified as a risk factor for liver cirrhosis and HCC because of the genetic variations at loci involved in the immune response [<xref ref-type="bibr" rid="RSOB180017C100">100</xref>].</p>
</sec>
<sec id="s6c">
<label>6.3.</label>
<title>A regulator or marker of certain cancers</title>
<p>Many people worldwide suffer from various cancers, particularly metastatic cancer. Cancer cells have more active motility, stronger drug resistance and a greater tolerance to the host immune system. Cancer cells acquiring anoikis resistance survive after detaching from their primary origin and spreading throughout the body through the circulatory and lymphatic systems. A functional genomics study identified that ABHD2 was a regulator of anoikis resistance in ovarian cancer [<xref ref-type="bibr" rid="RSOB180017C7">7</xref>]. The results showed that the silencing of ABHD2 could cause OVCA420 cell apoptosis resistance, and the overexpression of ABHD2 could decrease cell resistance to apoptosis. In addition, the expression of ABHD2 is lower in clinical serous ovarian cancer specimens [<xref ref-type="bibr" rid="RSOB180017C7">7</xref>]. Studies have suggested that the expression inhibition of ABHD2 may promote a malignant phenotype and contribute to an adverse prognosis in patients with serous ovarian cancer. ABHD4 is a novel regulator of anoikis sensitivity because ABHD4 knockdown could inhibit anoikis in prostate cells and reduce anoikis sensitivity in nasopharyngeal and ovarian cancer cells, while the overexpression of ABHD4 increased anoikis sensitivity [<xref ref-type="bibr" rid="RSOB180017C49">49</xref>]. A deficiency of ABHD5 could promote a shift of metabolism to aerobic glycolysis and contribute to colorectal carcinoma development and progression [<xref ref-type="bibr" rid="RSOB180017C55">55</xref>]. Moreover, ABHD5 was identified as a novel reliable marker for distinguishing sebaceous carcinoma from non-sebaceous tumours [<xref ref-type="bibr" rid="RSOB180017C56">56</xref>]. Compared with the expression seen in normal tissues, the high expression of ABHD6 in the Ewing sarcoma family of tumours suggested that ABHD6 might be a potential diagnostic marker or drug target [<xref ref-type="bibr" rid="RSOB180017C73">73</xref>]. The results from an expression quantitative trait locus (eQTL) analysis showed that the expression of ABHD8 was higher in breast cancer and ovarian cancer than that in normal corresponding organs [<xref ref-type="bibr" rid="RSOB180017C75">75</xref>]. Using an activity-based biomarker discovery platform, Wiedl <italic>et al</italic>. identified that ABHD11 is a novel biomarker that, through its activities, could predict the presence of aggressive lung adenocarcinomas and the development of distant metastases [<xref ref-type="bibr" rid="RSOB180017C81">81</xref>]. By analysing SNPs and copy number variations in the peripheral blood, Clifford <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180017C100">100</xref>] found that ABHD18 was an important factor in hepatocellular carcinoma in the Asian population.</p>
</sec>
<sec id="s6d">
<label>6.4.</label>
<title>A helper or restriction factor in virus infection</title>
<p>Using a human genome-wide bioarray, Ding <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180017C38">38</xref>] found that ABHD2 could contribute to the proliferation of hepatitis B viruses (HBVs) by analysing the differential expression of HBV-expressing and control cells through a wholegenome expression profiling of hepatitis B. The antisense oligodeoxynucleotides targeting ABHD2 successfully blocked the replication and expression of HBV [<xref ref-type="bibr" rid="RSOB180017C38">38</xref>]. Vieyres <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180017C103">103</xref>] demonstrated that ABHD5 was a new host factor contributing to virus morphogenesis in hepatitis C virus production and could trigger the mobilization and consumption of the luminal lipid droplet, which is important for the envelopment, maturation and budding of infectious virions. Our latest results show that ABHD16A inhibits the proliferation of Japanese encephalitis virus (JX 2018, unpublished data). The finding above suggested that the ABHD proteins might be potential targets in therapies for viral infectious diseases.</p>
</sec>
<sec id="s6e">
<label>6.5.</label>
<title>A key gene in other diseases</title>
<p>ABHD2 was found to be a critical gene in chronic obstructive pulmonary disease (COPD) by evaluating the genetic variation in the ABHD2 gene among Han Chinese COPD patients and normal controls [<xref ref-type="bibr" rid="RSOB180017C41">41</xref>]. The analysis of the DNA methylation data of genes throughout the genome showed that COPD is associated with DNA methylation at the CpG sites of the ABHD16B gene [<xref ref-type="bibr" rid="RSOB180017C96">96</xref>]. A mutation of the ABHD5 gene could lead to a rare genetic disorder called Chanarin-Dorfman Syndrome because such patients accumulate excess triacylglycerol caused by a functional defect in ABHD5 in certain tissues and ichthyosis [<xref ref-type="bibr" rid="RSOB180017C52">52</xref>,<xref ref-type="bibr" rid="RSOB180017C53">53</xref>]. In addition, a reduction in the ABHD5 expression levels in the heart may aggravate myocardial steatosis, oxidative stress and diabetic cardiomyopathy [<xref ref-type="bibr" rid="RSOB180017C63">63</xref>]. ABHD6, which is an MAG hydrolase, stimulated insulin secretion induced by glucose in pancreatic beta cells, participated in the regulation of energy homeostasis via PPAR gamma and may represent a new drug target for obesity and type 2 diabetes [<xref ref-type="bibr" rid="RSOB180017C72">72</xref>]. Based on genome-wide association studies investigating chronic periodontitis, Rhodin <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180017C86">86</xref>] found that ABHD12B was associated with chronic periodontitis and worthy of further investigation. ABHD14A was identified as a candidate gene for autism spectrum disorder in an analysis of homozygous haplotype mapping of SNPs [<xref ref-type="bibr" rid="RSOB180017C88">88</xref>].</p>
</sec>
</sec>
<sec id="s7">
<label>7.</label>
<title>Conclusion and perspectives</title>
<p>Here, we analysed the gene and protein structure, molecular evolution and existing or presumed functions of ABHD16A, and reviewed the functions of the other ABHD family members. Based on previous findings, we highlight the important roles played by the ABHDs during the occurrence and development of diseases related to lipid metabolism and inflammation.</p>
<p>Human ABHD16A might be a potential diagnostic marker of inflammatory-related diseases or play critical roles in the progress of such diseases. The high conservation of its amino acid sequences, lipase motifs and acyltransferase motifs indicates to a certain extent the necessity of this gene for specific cellular functions in mammalian species. ABHD16A not only participates in lipid metabolism but is also involved in the regulation of inflammation and immunity. Many studies have shown that other members of the ABHD protein family are associated with different diseases, such as cancer, lipid metabolism, liver disease and pulmonary disease. Studies investigating these proteins could not only enhance our understanding of the molecular mechanisms of related illnesses but also contribute to screening novel targets and new drugs. The regulation of virus infection suggested that ABHD could not be ignored as a potential marker or target, especially in an era of emerging and re-emerging viruses that unexpectedly appear.</p>
<p>Therefore, the following are potential future directions: (i) the identification or establishment of the inner link between the ABHD proteins and diseases; (ii) the identification of the enzymatic characteristics of ABHD proteins whose activity remains unknown; (iii) the exploration of the molecular mechanisms or pathways of disease-related ABHD proteins; (iv) the screening of proteins interacting with ABHD, especially in the field of intracellular transport and acylation modification (although ABHD16A and ABHD17 could be involved in the palmitoylation/depalmitoylation cycle, protein transport, organelle localization or special functions [<xref ref-type="bibr" rid="RSOB180017C10">10</xref>,<xref ref-type="bibr" rid="RSOB180017C104">104</xref>,<xref ref-type="bibr" rid="RSOB180017C105">105</xref>], their mechanism and targets must be further studied); and (v) the establishment of model cells or animals. The proper experimental model is crucial for studies investigating diseases. Some techniques (e.g. siRNA or CRISPR/CAS9) have been widely used in studies examining molecular mechanisms, especially of human diseases. Tissue-specific or conditional transgenic mice and gene knockout mice are needed if the offspring have a lower positive rate or the knockout leads to a failure in embryogenesis.</p>
<p>In conclusion, the human ABHD protein family has many members and performs a variety of biological functions. These proteins could play an important role in the regulation of lipid metabolism and signalling transduction pathways, and are possibly directly or indirectly correlated with several human diseases. Although interesting results have been obtained, the functions and molecular mechanisms remain unclear and should be explored in more detail in the future. For researchers, studies in this field could be promising, interesting and significant, especially for understanding several human diseases.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors thank Zihan Li and American Journal Experts for their contribution in modifying the figures and polishing the manuscript.</p>
</ack>
<sec id="s8" sec-type="dataaccess">
<title>Data accessibility</title>
<p>This article has no additional data.</p>
</sec>
<sec id="s9" sec-type="aucontribute">
<title>Authors' contributions</title>
<p>All authors contributed to the production of this article.</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that there are no conflicts of interest. The founding sponsors played no role in the design of this study; the collection, analyses or interpretation of the data; the writing of the manuscript; or the decision to publish the results.</p>
</sec>
<sec id="s11" sec-type="funding">
<title>Funding</title>
<p>This project was financially supported by grants from the Preferred Foundation for Returned Scholar from Overseas of Ministry of Human Resources and Social Security of China (Study abroad personnel and expert service centre of Henan Province) (2017-2).</p>
</sec>
<ref-list>
<title>References</title>
<ref id="RSOB180017C1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turcotte</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zarini</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jean</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Marsolais</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Laviolette</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Blanchet</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Flamand</surname><given-names>N</given-names></name></person-group>
<year>2017</year>
<article-title>The endocannabinoid metabolite prostaglandin E2 (PGE2)-Glycerol inhibits human neutrophil functions: involvement of its hydrolysis into PGE2 and EP Receptors</article-title>. <source/>J. Immunol.
<volume>198</volume>, <fpage>3255</fpage>–<lpage>3263</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1601767">doi:10.4049/jimmunol.1601767</ext-link>)<pub-id pub-id-type="pmid">28258202</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Camara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Parsons</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Dix</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Howell</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name></person-group>
<year>2015</year>
<article-title>Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay</article-title>. <source/>Nat. Chem. Biol.
<volume>11</volume>, <fpage>164</fpage>–<lpage>171</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nchembio.1721">doi:10.1038/nchembio.1721</ext-link>)<pub-id pub-id-type="pmid">25580854</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>DY</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>FJ</given-names></name></person-group>
<year>2010</year>
<article-title>Human lymphocyte antigen B-associated transcript 2, 3, and 5 polymorphisms and haplotypes are associated with susceptibility of Kawasaki disease and coronary artery aneurysm</article-title>. <source/>J. Clin. Lab. Anal.
<volume>24</volume>, <fpage>262</fpage>–<lpage>268</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jcla.20409">doi:10.1002/jcla.20409</ext-link>)<pub-id pub-id-type="pmid">20626023</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ollis</surname><given-names>DL</given-names></name><etal>et al.</etal></person-group>
<year>1992</year>
<article-title>The alpha/beta hydrolase fold</article-title>. <source/>Protein Eng.
<volume>5</volume>, <fpage>197</fpage>–<lpage>211</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/protein/5.3.197">doi:10.1093/protein/5.3.197</ext-link>)<pub-id pub-id-type="pmid">1409539</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nardini</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dijkstra</surname><given-names>BW</given-names></name></person-group>
<year>1999</year>
<article-title>Alpha/beta hydrolase fold enzymes: the family keeps growing</article-title>. <source/>Curr. Opin Struct. Biol.
<volume>9</volume>, <fpage>732</fpage>–<lpage>737</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0959-440X(99)00037-8">doi:10.1016/S0959-440X(99)00037-8</ext-link>)<pub-id pub-id-type="pmid">10607665</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lord</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>JM</given-names></name></person-group>
<year>2013</year>
<article-title>Mammalian alpha beta hydrolase domain (ABHD) proteins: lipid metabolizing enzymes at the interface of cell signaling and energy metabolism</article-title>. <source/>Biochim. Biophys. Acta
<volume>1831</volume>, <fpage>792</fpage>–<lpage>802</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbalip.2013.01.002">doi:10.1016/j.bbalip.2013.01.002</ext-link>)<pub-id pub-id-type="pmid">23328280</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamanoi</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer</article-title>. <source/>Oncotarget
<volume>7</volume>, <fpage>47 620</fpage>–<lpage>47 636</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.18632/oncotarget.9951">doi:10.18632/oncotarget.9951</ext-link>)</mixed-citation>
</ref>
<ref id="RSOB180017C8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poursharifi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Madiraju</surname><given-names>SRM</given-names></name>, <name name-style="western"><surname>Prentki</surname><given-names>M</given-names></name></person-group>
<year>2017</year>
<article-title>Monoacylglycerol signalling and ABHD6 in health and disease</article-title>. <source/>Diabetes Obes. Metab.
<volume>19</volume>(<issue>Suppl. 1</issue>), <fpage>76</fpage>–<lpage>89</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/dom.13008">doi:10.1111/dom.13008</ext-link>)<pub-id pub-id-type="pmid">28880480</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tingaud-Sequeira</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC</article-title>. <source/>Neurobiol. Dis.
<volume>98</volume>, <fpage>36</fpage>–<lpage>51</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.nbd.2016.11.008">doi:10.1016/j.nbd.2016.11.008</ext-link>)<pub-id pub-id-type="pmid">27890673</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yokoi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fukata</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sekiya</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Murakami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fukata</surname><given-names>M</given-names></name></person-group>
<year>2016</year>
<article-title>Identification of PSD-95 depalmitoylating enzymes</article-title>. <source/>J. Neurosci.
<volume>36</volume>, <fpage>6431</fpage>–<lpage>6444</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1523/JNEUROSCI.0419-16.2016">doi:10.1523/JNEUROSCI.0419-16.2016</ext-link>)<pub-id pub-id-type="pmid">27307232</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spies</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bresnahan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Strominger</surname><given-names>JL</given-names></name></person-group>
<year>1989</year>
<article-title>Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>86</volume>, <fpage>8955</fpage>–<lpage>8958</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.86.22.8955">doi:10.1073/pnas.86.22.8955</ext-link>)<pub-id pub-id-type="pmid">2813433</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spies</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Blanck</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bresnahan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sands</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Strominger</surname><given-names>JL</given-names></name></person-group>
<year>1989</year>
<article-title>A new cluster of genes within the human major histocompatibility complex</article-title>. <source/>Science
<volume>243</volume>, <fpage>214</fpage>–<lpage>217</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.2911734">doi:10.1126/science.2911734</ext-link>)<pub-id pub-id-type="pmid">2911734</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sargent</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Dunham</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>RD</given-names></name></person-group>
<year>1989</year>
<article-title>Identification of multiple HTF-island associated genes in the human major histocompatibility complex class III region</article-title>. <source/>EMBO J.
<volume>8</volume>, <fpage>2305</fpage>–<lpage>2312</lpage>.<pub-id pub-id-type="pmid">2477242</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albertella</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Thomson</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Olavesen</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>RD</given-names></name></person-group>
<year>1996</year>
<article-title>Localization of eight additional genes in the human major histocompatibility complex, including the gene encoding the casein kinase II beta subunit (CSNK2B)</article-title>. <source/>Genomics
<volume>36</volume>, <fpage>240</fpage>–<lpage>251</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/geno.1996.0459">doi:10.1006/geno.1996.0459</ext-link>)<pub-id pub-id-type="pmid">8812450</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikegami</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kawaguchi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fukuda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Takakawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fujioka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fujisawa</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Uchida</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ogihara</surname><given-names>T</given-names></name></person-group>
<year>1993</year>
<article-title>MHC-linked diabetogenic gene of the NOD mouse: molecular mapping of the 3′ boundary of the diabetogenic region</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>192</volume>, <fpage>677</fpage>–<lpage>682</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/bbrc.1993.1468">doi:10.1006/bbrc.1993.1468</ext-link>)<pub-id pub-id-type="pmid">8097912</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanishvili</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>
<year>2003</year>
<article-title>Integrating structure, bioinformatics, and enzymology to discover function: BioH, a new carboxylesterase from <italic>Escherichia coli</italic></article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>26 039</fpage>–<lpage>26 045</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M303867200">doi:10.1074/jbc.M303867200</ext-link>)</mixed-citation>
</ref>
<ref id="RSOB180017C17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomczyk</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Nettleship</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Baxter</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Crichton</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Webster</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Campopiano</surname><given-names>DJ</given-names></name></person-group>
<year>2002</year>
<article-title>Purification and characterisation of the BIOH protein from the biotin biosynthetic pathway</article-title>. <source/>FEBS Lett.
<volume>513</volume>, <fpage>299</fpage>–<lpage>304</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0014-5793(02)02342-6">doi:10.1016/S0014-5793(02)02342-6</ext-link>)<pub-id pub-id-type="pmid">11904168</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parkkari</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Discovery of triterpenoids as reversible inhibitors of alpha/beta-hydrolase domain containing 12 (ABHD12)</article-title>. <source/>PLoS ONE
<volume>9</volume>, <fpage>e98286</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0098286">doi:10.1371/journal.pone.0098286</ext-link>)<pub-id pub-id-type="pmid">24879289</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savinainen</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>JZ</given-names></name>, <name name-style="western"><surname>Parkkari</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Navia-Paldanius</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Marjamaa</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Laitinen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nevalainen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Laitinen</surname><given-names>JT</given-names></name></person-group>
<year>2014</year>
<article-title>Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A)</article-title>. <source/>PLoS ONE
<volume>9</volume>, <fpage>e109869</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0109869">doi:10.1371/journal.pone.0109869</ext-link>)<pub-id pub-id-type="pmid">25290914</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>JM</given-names></name></person-group>
<year>2014</year>
<article-title>In vivo metabolite profiling as a means to identify uncharacterized lipase function: recent success stories within the alpha beta hydrolase domain (ABHD) enzyme family</article-title>. <source/>Biochim. Biophys. Acta
<volume>1841</volume>, <fpage>1097</fpage>–<lpage>1101</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbalip.2014.01.004">doi:10.1016/j.bbalip.2014.01.004</ext-link>)<pub-id pub-id-type="pmid">24423940</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathew</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Flaherty</surname><given-names>L</given-names></name></person-group>
<year>1995</year>
<article-title>Identification of a recombinational breakpoint at the BAT5 locus in three intra-H-2 recombinant inbred mouse strains</article-title>. <source/>Exp. Clin. Immunogenet.
<volume>12</volume>, <fpage>261</fpage>–<lpage>267</lpage>.<pub-id pub-id-type="pmid">8919359</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fiskerstrand</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism</article-title>. <source/>Am. J. Hum. Genet.
<volume>87</volume>, <fpage>410</fpage>–<lpage>417</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajhg.2010.08.002">doi:10.1016/j.ajhg.2010.08.002</ext-link>)<pub-id pub-id-type="pmid">20797687</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>DH</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects</article-title>. <source/>Hum. Mutat.
<volume>34</volume>, <fpage>1672</fpage>–<lpage>1678</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/humu.22437">doi:10.1002/humu.22437</ext-link>)<pub-id pub-id-type="pmid">24027063</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blankman</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>JZ</given-names></name>, <name name-style="western"><surname>Trauger</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Siuzdak</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name></person-group>
<year>2013</year>
<article-title>ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>110</volume>, <fpage>1500</fpage>–<lpage>1505</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1217121110">doi:10.1073/pnas.1217121110</ext-link>)<pub-id pub-id-type="pmid">23297193</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontanesi</surname><given-names>L</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Identification and association analysis of several hundred single nucleotide polymorphisms within candidate genes for back fat thickness in Italian Large White pigs using a selective genotyping approach</article-title>. <source/>J. Anim. Sci.
<volume>90</volume>, <fpage>2450</fpage>–<lpage>2464</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2527/jas.2011-4797">doi:10.2527/jas.2011-4797</ext-link>)<pub-id pub-id-type="pmid">22367074</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lehner</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Semple</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Counsell</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Sanderson</surname><given-names>CM</given-names></name></person-group>
<year>2004</year>
<article-title>Analysis of a high-throughput yeast two-hybrid system and its use to predict the function of intracellular proteins encoded within the human MHC class III region</article-title>. <source/>Genomics
<volume>83</volume>, <fpage>153</fpage>–<lpage>167</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0888-7543(03)00235-0">doi:10.1016/S0888-7543(03)00235-0</ext-link>)<pub-id pub-id-type="pmid">14667819</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Circulating ‘lncRNA OTTHUMT00000387022′ from monocytes as a novel biomarker for coronary artery disease</article-title>. <source/>Cardiovasc. Res.
<volume>112</volume>, <fpage>714</fpage>–<lpage>724</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/cvr/cvw022">doi:10.1093/cvr/cvw022</ext-link>)<pub-id pub-id-type="pmid">26857419</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vigorito</surname><given-names>E</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells</article-title>. <source/>Immunity
<volume>27</volume>, <fpage>847</fpage>–<lpage>859</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.immuni.2007.10.009">doi:10.1016/j.immuni.2007.10.009</ext-link>)<pub-id pub-id-type="pmid">18055230</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Roon-Mom</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Pepers</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>'t Hoen</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Verwijmeren</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>den Dunnen</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Dorsman</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>van Ommen</surname><given-names>GB</given-names></name></person-group>
<year>2008</year>
<article-title>Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease</article-title>. <source/>BMC Mol. Biol.
<volume>9</volume>, <fpage>84</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2199-9-84">doi:10.1186/1471-2199-9-84</ext-link>)<pub-id pub-id-type="pmid">18844975</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoelting</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Geyer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Reuter</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Reichelt</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bek</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Pavenstadt</surname><given-names>H</given-names></name></person-group>
<year>2009</year>
<article-title>Alpha/beta hydrolase 1 is upregulated in D5 dopamine receptor knockout mice and reduces O2- production of NADPH oxidase</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>379</volume>, <fpage>81</fpage>–<lpage>85</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrc.2008.12.008">doi:10.1016/j.bbrc.2008.12.008</ext-link>)<pub-id pub-id-type="pmid">19073140</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohman</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Rodriguez-Zas</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Southey</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Dantzer</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rhodes</surname><given-names>JS</given-names></name></person-group>
<year>2011</year>
<article-title>Voluntary wheel running reverses age-induced changes in hippocampal gene expression</article-title>. <source/>PLoS ONE
<volume>6</volume>, <fpage>e22654</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0022654">doi:10.1371/journal.pone.0022654</ext-link>)<pub-id pub-id-type="pmid">21857943</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kierstein</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Noyes</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Naessens</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pritchard</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kemp</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brass</surname><given-names>A</given-names></name></person-group>
<year>2006</year>
<article-title>Gene expression profiling in a mouse model for African trypanosomiasis</article-title>. <source/>Genes Immun.
<volume>7</volume>, <fpage>667</fpage>–<lpage>679</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.gene.6364345">doi:10.1038/sj.gene.6364345</ext-link>)<pub-id pub-id-type="pmid">17066074</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fowler</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Zecchini</surname><given-names>VR</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>PH</given-names></name></person-group>
<year>2011</year>
<article-title>Intestinal activation of Notch signaling induces rapid onset hepatic steatosis and insulin resistance</article-title>. <source/>PLoS ONE
<volume>6</volume>, <fpage>e20767</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0020767">doi:10.1371/journal.pone.0020767</ext-link>)<pub-id pub-id-type="pmid">21698231</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Thunuguntla</surname><given-names>VB</given-names></name>, <name name-style="western"><surname>Veeramachaneni</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Guntupalli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bondili</surname><given-names>JS</given-names></name></person-group>
<year>2016</year>
<article-title>Molecular characterization of human ABHD2 as TAG lipase and ester hydrolase</article-title>. <source/>Biosci. Rep.
<volume>36</volume>, <fpage>e00358</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1042/BSR20160033">doi:10.1042/BSR20160033</ext-link>)<pub-id pub-id-type="pmid">27247428</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>MR</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone</article-title>. <source/>Science
<volume>352</volume>, <fpage>555</fpage>–<lpage>559</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.aad6887">doi:10.1126/science.aad6887</ext-link>)<pub-id pub-id-type="pmid">26989199</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mannowetz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Lishko</surname><given-names>PV</given-names></name></person-group>
<year>2017</year>
<article-title>Regulation of the sperm calcium channel CatSper by endogenous steroids and plant triterpenoids</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>114</volume>, <fpage>5743</fpage>–<lpage>5748</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1700367114">doi:10.1073/pnas.1700367114</ext-link>)<pub-id pub-id-type="pmid">28507119</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obinata</surname><given-names>D</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration</article-title>. <source/>Eur. J. Cancer
<volume>57</volume>, <fpage>39</fpage>–<lpage>49</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejca.2016.01.002">doi:10.1016/j.ejca.2016.01.002</ext-link>)<pub-id pub-id-type="pmid">26854828</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S</given-names></name></person-group>
<year>2011</year>
<article-title>Antisense oligonucleotides targeting abhydrolase domain containing 2 block human hepatitis B virus propagation</article-title>. <source/>Oligonucleotides
<volume>21</volume>, <fpage>77</fpage>–<lpage>84</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/oli.2011.0280">doi:10.1089/oli.2011.0280</ext-link>)<pub-id pub-id-type="pmid">21466387</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>XR</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Lou</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>SQ</given-names></name></person-group>
<year>2008</year>
<article-title>Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs</article-title>. <source/>Pharmacogenomics J
<volume>8</volume>, <fpage>61</fpage>–<lpage>70</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.tpj.6500459">doi:10.1038/sj.tpj.6500459</ext-link>)<pub-id pub-id-type="pmid">17505500</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yun</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Reisdorph</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ewing</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gelb</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Leslie</surname><given-names>CC</given-names></name></person-group>
<year>2017</year>
<article-title>Regulation of calcium release from the endoplasmic reticulum by the serine hydrolase ABHD2</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>490</volume>, <fpage>1226</fpage>–<lpage>1231</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrc.2017.06.195">doi:10.1016/j.bbrc.2017.06.195</ext-link>)<pub-id pub-id-type="pmid">28684316</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Qiang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title>Associations of ABHD2 genetic variations with risks for chronic obstructive pulmonary disease in a Chinese Han population</article-title>. <source/>PLoS ONE
<volume>10</volume>, <fpage>e0123929</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0123929">doi:10.1371/journal.pone.0123929</ext-link>)<pub-id pub-id-type="pmid">25880496</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data</article-title>. <source/>Cancer Inform.
<volume>9</volume>, <fpage>147</fpage>–<lpage>161</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4137/CIN.S3851">doi:10.4137/CIN.S3851</ext-link>)<pub-id pub-id-type="pmid">20706620</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Itoh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fujiwara</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kodama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Aburatani</surname><given-names>H</given-names></name></person-group>
<year>2006</year>
<article-title>Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>340</volume>, <fpage>758</fpage>–<lpage>766</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrc.2005.12.068">doi:10.1016/j.bbrc.2005.12.068</ext-link>)<pub-id pub-id-type="pmid">16380080</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nomura</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Blankman</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Fujioka</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Issa</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Casida</surname><given-names>JE</given-names></name></person-group>
<year>2008</year>
<article-title>Activation of the endocannabinoid system by organophosphorus nerve agents</article-title>. <source/>Nat. Chem. Biol.
<volume>4</volume>, <fpage>373</fpage>–<lpage>378</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nchembio.86">doi:10.1038/nchembio.86</ext-link>)<pub-id pub-id-type="pmid">18438404</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>JZ</given-names></name>, <name name-style="western"><surname>Cisar</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Milliken</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Niessen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Trauger</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Siuzdak</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name></person-group>
<year>2011</year>
<article-title>Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipids</article-title>. <source/>Nat. Chem. Biol.
<volume>7</volume>, <fpage>763</fpage>–<lpage>765</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nchembio.659">doi:10.1038/nchembio.659</ext-link>)<pub-id pub-id-type="pmid">21926997</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez-Becker</surname><given-names>NQ</given-names></name>, <name name-style="western"><surname>Moss</surname><given-names>AC</given-names></name></person-group>
<year>2009</year>
<article-title>In silico analysis of T-bet activity in peripheral blood mononuclear cells in patients with inflammatory bowel disease (IBD)</article-title>. <source/>In Silico Biol.
<volume>9</volume>, <fpage>355</fpage>–<lpage>363</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3233/ISB-2009-0410">doi:10.3233/ISB-2009-0410</ext-link>)<pub-id pub-id-type="pmid">22430437</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>
<year>2008</year>
<article-title>Multiple pathways involved in the biosynthesis of anandamide</article-title>. <source/>Neuropharmacology
<volume>54</volume>, <fpage>1</fpage>–<lpage>7</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuropharm.2007.05.020">doi:10.1016/j.neuropharm.2007.05.020</ext-link>)<pub-id pub-id-type="pmid">17631919</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name></person-group>
<year>2006</year>
<article-title>Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>26 465</fpage>–<lpage>26 472</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M604660200">doi:10.1074/jbc.M604660200</ext-link>)</mixed-citation>
</ref>
<ref id="RSOB180017C49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Hurren</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kasimer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>MacLean</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Eberhard</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ketela</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Moffat</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schimmer</surname><given-names>AD</given-names></name></person-group>
<year>2012</year>
<article-title>A genome wide shRNA screen identifies alpha/beta hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistance</article-title>. <source/>Apoptosis
<volume>17</volume>, <fpage>666</fpage>–<lpage>678</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10495-012-0723-4">doi:10.1007/s10495-012-0723-4</ext-link>)<pub-id pub-id-type="pmid">22488300</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C</given-names></name></person-group>
<year>2016</year>
<article-title>Macrophage CGI-58 attenuates inflammatory responsiveness via promotion of PPARgamma signaling</article-title>. <source/>Cell. Physiol. Biochem.
<volume>38</volume>, <fpage>696</fpage>–<lpage>713</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000443027">doi:10.1159/000443027</ext-link>)<pub-id pub-id-type="pmid">26872126</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Ramakrishnan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chandramohan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rajasekharan</surname><given-names>R</given-names></name></person-group>
<year>2008</year>
<article-title>CGI-58, the causative gene for chanarin-dorfman syndrome, mediates acylation of lysophosphatidic acid</article-title>. <source/>J. Biol. Chem.
<volume>283</volume>, <fpage>24 525</fpage>–<lpage>24 533</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M801783200">doi:10.1074/jbc.M801783200</ext-link>)</mixed-citation>
</ref>
<ref id="RSOB180017C52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeichi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sugiura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tso</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Simpson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>McGrath</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Akiyama</surname><given-names>M</given-names></name></person-group>
<year>2016</year>
<article-title>Bi-allelic nonsense mutations inABHD5 underlie a mild phenotype of dorfman-chanarin syndrome</article-title>. <source/>J. Dermatol. Sci.
<volume>81</volume>, <fpage>134</fpage>–<lpage>136</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jdermsci.2015.10.015">doi:10.1016/j.jdermsci.2015.10.015</ext-link>)<pub-id pub-id-type="pmid">26547112</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lass</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2006</year>
<article-title>Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman syndrome</article-title>. <source/>Cell Metab.
<volume>3</volume>, <fpage>309</fpage>–<lpage>319</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cmet.2006.03.005">doi:10.1016/j.cmet.2006.03.005</ext-link>)<pub-id pub-id-type="pmid">16679289</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dettlaff-Pokora</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sledzinski</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Swierczynski</surname><given-names>J</given-names></name></person-group>
<year>2016</year>
<article-title>Upregulation of Pnpla2 and Abhd5 and downregulation of G0s2 gene expression in mesenteric white adipose tissue as a potential reason for elevated concentration of circulating NEFA after removal of retroperitoneal, epididymal, and inguinal adipose tissue</article-title>. <source/>Mol. Cell. Biochem.
<volume>422</volume>, <fpage>21</fpage>–<lpage>29</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11010-016-2800-4">doi:10.1007/s11010-016-2800-4</ext-link>)<pub-id pub-id-type="pmid">27590244</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ou</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition</article-title>. <source/>Cell Rep.
<volume>9</volume>, <fpage>1798</fpage>–<lpage>1811</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2014.11.016">doi:10.1016/j.celrep.2014.11.016</ext-link>)<pub-id pub-id-type="pmid">25482557</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lind</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>D</given-names></name></person-group>
<year>2013</year>
<article-title>Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features</article-title>. <source/>J. Cutan. Pathol.
<volume>40</volume>, <fpage>631</fpage>–<lpage>638</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/cup.12147">doi:10.1111/cup.12147</ext-link>)<pub-id pub-id-type="pmid">23557589</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>D</given-names></name></person-group>
<year>2014</year>
<article-title>Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice</article-title>. <source/>Biochim. Biophys. Acta
<volume>1841</volume>, <fpage>1683</fpage>–<lpage>1690</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbalip.2014.08.014">doi:10.1016/j.bbalip.2014.08.014</ext-link>)<pub-id pub-id-type="pmid">25178844</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>L</given-names></name></person-group>
<year>2014</year>
<article-title>Intestinal Cgi-58 deficiency reduces postprandial lipid absorption</article-title>. <source/>PLoS ONE
<volume>9</volume>, <fpage>e91652</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0091652">doi:10.1371/journal.pone.0091652</ext-link>)<pub-id pub-id-type="pmid">24618586</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Deficiency of liver comparative gene identification-58 causes steatohepatitis and fibrosis in mice</article-title>. <source/>J. Lipid Res.
<volume>54</volume>, <fpage>2109</fpage>–<lpage>2120</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1194/jlr.M035519">doi:10.1194/jlr.M035519</ext-link>)<pub-id pub-id-type="pmid">23733885</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lord</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>JM</given-names></name></person-group>
<year>2012</year>
<article-title>Distinct roles for alpha-beta hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling</article-title>. <source/>Adipocyte
<volume>1</volume>, <fpage>123</fpage>–<lpage>131</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4161/adip.20035">doi:10.4161/adip.20035</ext-link>)<pub-id pub-id-type="pmid">23145367</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cantley</surname><given-names>JL</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>110</volume>, <fpage>1869</fpage>–<lpage>1874</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1219456110">doi:10.1073/pnas.1219456110</ext-link>)<pub-id pub-id-type="pmid">23302688</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schweiger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lass</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zimmermann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Eichmann</surname><given-names>TO</given-names></name>, <name name-style="western"><surname>Zechner</surname><given-names>R</given-names></name></person-group>
<year>2009</year>
<article-title>Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5</article-title>. <source/>Am. J. Physiol. Endocrinol. Metab.
<volume>297</volume>, <fpage>E289</fpage>–<lpage>E296</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajpendo.00099.2009">doi:10.1152/ajpendo.00099.2009</ext-link>)<pub-id pub-id-type="pmid">19401457</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db/db mice</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>438</volume>, <fpage>224</fpage>–<lpage>229</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrc.2013.07.063">doi:10.1016/j.bbrc.2013.07.063</ext-link>)<pub-id pub-id-type="pmid">23886955</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pribasnig</surname><given-names>MA</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>alpha/beta hydrolase domain-containing 6 (ABHD6) degrades the late endosomal/lysosomal lipid bis(monoacylglycero)phosphate</article-title>. <source/>J. Biol. Chem.
<volume>290</volume>, <fpage>29 869</fpage>–<lpage>29 881</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M115.669168">doi:10.1074/jbc.M115.669168</ext-link>)</mixed-citation>
</ref>
<ref id="RSOB180017C65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savinainen</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Saario</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Laitinen</surname><given-names>JT</given-names></name></person-group>
<year>2012</year>
<article-title>The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors</article-title>. <source/>Acta Physiol.
<volume>204</volume>, <fpage>267</fpage>–<lpage>276</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1748-1716.2011.02280.x">doi:10.1111/j.1748-1716.2011.02280.x</ext-link>)</mixed-citation>
</ref>
<ref id="RSOB180017C66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrs</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Horne</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Ortega-Gutierrez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cisneros</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Muccioli</surname><given-names>GG</given-names></name>, <name name-style="western"><surname>Lopez-Rodriguez</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Stella</surname><given-names>N</given-names></name></person-group>
<year>2011</year>
<article-title>Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons</article-title>. <source/>J. Biol. Chem.
<volume>286</volume>, <fpage>28 723</fpage>–<lpage>28 728</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M110.202853">doi:10.1074/jbc.M110.202853</ext-link>)</mixed-citation>
</ref>
<ref id="RSOB180017C67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrs</surname><given-names>WR</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors</article-title>. <source/>Nat. Neurosci.
<volume>13</volume>, <fpage>951</fpage>–<lpage>957</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nn.2601">doi:10.1038/nn.2601</ext-link>)<pub-id pub-id-type="pmid">20657592</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oparina</surname><given-names>NY</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6</article-title>. <source/>Ann. Rheum. Dis.
<volume>74</volume>, <fpage>e14</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/annrheumdis-2013-204909">doi:10.1136/annrheumdis-2013-204909</ext-link>)<pub-id pub-id-type="pmid">24534757</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>alpha/beta-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>113</volume>, <fpage>E2695</fpage>–<lpage>E2704</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1524589113">doi:10.1073/pnas.1524589113</ext-link>)<pub-id pub-id-type="pmid">27114538</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>The inhibitory effect of alpha/beta-hydrolase domain-containing 6 (ABHD6) on the surface targeting of GluA2- and GluA3-Containing AMPA Receptors</article-title>. <source/>Front. Mol. Neurosci.
<volume>10</volume>, <fpage>55</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fnmol.2017.00055">doi:10.3389/fnmol.2017.00055</ext-link>)<pub-id pub-id-type="pmid">28303090</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome</article-title>. <source/>Cell Rep.
<volume>5</volume>, <fpage>508</fpage>–<lpage>520</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2013.08.047">doi:10.1016/j.celrep.2013.08.047</ext-link>)<pub-id pub-id-type="pmid">24095738</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>alpha/beta-Hydrolase domain 6 deletion induces adipose browning and prevents obesity and Type 2 diabetes</article-title>. <source/>Cell Rep.
<volume>14</volume>, <fpage>2872</fpage>–<lpage>2888</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2016.02.076">doi:10.1016/j.celrep.2016.02.076</ext-link>)<pub-id pub-id-type="pmid">26997277</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Max</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hesse</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Volkmer</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Staege</surname><given-names>MS</given-names></name></person-group>
<year>2009</year>
<article-title>High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors</article-title>. <source/>Cancer Sci.
<volume>100</volume>, <fpage>2383</fpage>–<lpage>2389</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1349-7006.2009.01347.x">doi:10.1111/j.1349-7006.2009.01347.x</ext-link>)<pub-id pub-id-type="pmid">19793082</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Decker</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides</article-title>. <source/>J. Lipid Res.
<volume>53</volume>, <fpage>2038</fpage>–<lpage>2045</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1194/jlr.M024448">doi:10.1194/jlr.M024448</ext-link>)<pub-id pub-id-type="pmid">22798687</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawrenson</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus</article-title>. <source/>Nat. Commun.
<volume>7</volume>, <fpage>12675</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms12675">doi:10.1038/ncomms12675</ext-link>)<pub-id pub-id-type="pmid">27601076</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cottrell</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis</article-title>. <source/>J. Urol.
<volume>177</volume>, <fpage>1753</fpage>–<lpage>1758</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.juro.2007.01.010">doi:10.1016/j.juro.2007.01.010</ext-link>)<pub-id pub-id-type="pmid">17437806</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stott-Miller</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence</article-title>. <source/>Cancer Epidemiol. Biomarkers Prev.
<volume>23</volume>, <fpage>1331</fpage>–<lpage>1339</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/1055-9965.EPI-13-1000">doi:10.1158/1055-9965.EPI-13-1000</ext-link>)<pub-id pub-id-type="pmid">24718283</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iwamura</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fukami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Higuchi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nakajima</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yokoi</surname><given-names>T</given-names></name></person-group>
<year>2012</year>
<article-title>Human alpha/beta hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver</article-title>. <source/>J. Biol. Chem.
<volume>287</volume>, <fpage>9240</fpage>–<lpage>9249</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M111.271288">doi:10.1074/jbc.M111.271288</ext-link>)<pub-id pub-id-type="pmid">22294686</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yokoi</surname><given-names>T</given-names></name></person-group>
<year>2012</year>
<article-title>The emerging role of human esterases</article-title>. <source/>Drug Metab. Pharmacokinet
<volume>27</volume>, <fpage>466</fpage>–<lpage>477</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2133/dmpk.DMPK-12-RV-042">doi:10.2133/dmpk.DMPK-12-RV-042</ext-link>)<pub-id pub-id-type="pmid">22813719</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fukami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yokoi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nakajima</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>An orphan esterase ABHD10 modulates probenecid acyl glucuronidation in human liver</article-title>. <source/>Drug Metab. Dispos.
<volume>42</volume>, <fpage>2109</fpage>–<lpage>2116</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1124/dmd.114.059485">doi:10.1124/dmd.114.059485</ext-link>)<pub-id pub-id-type="pmid">25217485</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiedl</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Arni</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Roschitzki</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Grossmann</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Collaud</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Soltermann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hillinger</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aebersold</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Weder</surname><given-names>W</given-names></name></person-group>
<year>2011</year>
<article-title>Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma</article-title>. <source/>J. Proteomics
<volume>74</volume>, <fpage>1884</fpage>–<lpage>1894</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jprot.2011.04.030">doi:10.1016/j.jprot.2011.04.030</ext-link>)<pub-id pub-id-type="pmid">21596165</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Navia-Paldanius</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Savinainen</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Laitinen</surname><given-names>JT</given-names></name></person-group>
<year>2012</year>
<article-title>Biochemical and pharmacological characterization of human alpha/beta-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)</article-title>. <source/>J. Lipid Res.
<volume>53</volume>, <fpage>2413</fpage>–<lpage>2424</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1194/jlr.M030411">doi:10.1194/jlr.M030411</ext-link>)<pub-id pub-id-type="pmid">22969151</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshimura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hashimoto</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Murata</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Fukushima</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sugaya</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nishio</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Usami</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title>Novel ABHD12 mutations in PHARC patients: the differential diagnosis of deaf-blindness</article-title>. <source/>Ann. Otol. Rhinol. Laryngol.
<volume>124</volume>(<issue>Suppl. 1</issue>), <fpage>77S</fpage>–<lpage>83S</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/0003489415574513">doi:10.1177/0003489415574513</ext-link>)<pub-id pub-id-type="pmid">25743180</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lerat</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cintas</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Beauvais-Dzugan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Magdelaine</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sturtz</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lia</surname><given-names>AS</given-names></name></person-group>
<year>2017</year>
<article-title>A complex homozygous mutation in ABHD12 responsible for PHARC syndrome discovered with NGS and review of the literature</article-title>. <source/>J. Peripher. Nerv. Syst.
<volume>22</volume>, <fpage>77</fpage>–<lpage>84</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/jns.12216">doi:10.1111/jns.12216</ext-link>)<pub-id pub-id-type="pmid">28448692</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kogelman</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Zhernakova</surname><given-names>DV</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Cirera</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fredholm</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Franke</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kadarmideen</surname><given-names>HN</given-names></name></person-group>
<year>2015</year>
<article-title>An integrative systems genetics approach reveals potential causal genes and pathways related to obesity</article-title>. <source/>Genome Med.
<volume>7</volume>, <fpage>105</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s13073-015-0229-0">doi:10.1186/s13073-015-0229-0</ext-link>)<pub-id pub-id-type="pmid">26482556</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rhodin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Divaris</surname><given-names>K</given-names></name>, <name name-style="western"><surname>North</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Barros</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Moss</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Beck</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Offenbacher</surname><given-names>S</given-names></name></person-group>
<year>2014</year>
<article-title>Chronic periodontitis genome-wide association studies: gene-centric and gene set enrichment analyses</article-title>. <source/>J. Dent. Res.
<volume>93</volume>, <fpage>882</fpage>–<lpage>890</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/0022034514544506">doi:10.1177/0022034514544506</ext-link>)<pub-id pub-id-type="pmid">25056994</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koran</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Hohman</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Meda</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Thornton-Wells</surname><given-names>TA</given-names></name></person-group>
<year>2014</year>
<article-title>Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size</article-title>. <source/>J. Alzheimers Dis.
<volume>38</volume>, <fpage>145</fpage>–<lpage>154</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3233/JAD-130989">doi:10.3233/JAD-130989</ext-link>)<pub-id pub-id-type="pmid">24077433</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casey</surname><given-names>JP</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder</article-title>. <source/>Hum. Genet.
<volume>131</volume>, <fpage>565</fpage>–<lpage>579</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00439-011-1094-6">doi:10.1007/s00439-011-1094-6</ext-link>)<pub-id pub-id-type="pmid">21996756</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoshino</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aruga</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ishiguro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mikoshiba</surname><given-names>K</given-names></name></person-group>
<year>2003</year>
<article-title>Dorz1, a novel gene expressed in differentiating cerebellar granule neurons, is down-regulated in Zic1-deficient mouse</article-title>. <source/>Brain Res. Mol. Brain Res.
<volume>120</volume>, <fpage>57</fpage>–<lpage>64</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.molbrainres.2003.10.004">doi:10.1016/j.molbrainres.2003.10.004</ext-link>)<pub-id pub-id-type="pmid">14667578</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Padmanabhan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kuzuhara</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Adachi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Horikoshi</surname><given-names>M</given-names></name></person-group>
<year>2004</year>
<article-title>The crystal structure of CCG1/TAF(II)250-interacting factor B (CIB)</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>9615</fpage>–<lpage>9624</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M312165200">doi:10.1074/jbc.M312165200</ext-link>)<pub-id pub-id-type="pmid">14672934</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Posorski</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kaemmerer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Grabowski</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hoersch</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hommann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>von Eggeling</surname><given-names>F</given-names></name></person-group>
<year>2011</year>
<article-title>Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases</article-title>. <source/>Clin. Exp. Metastasis
<volume>28</volume>, <fpage>637</fpage>–<lpage>647</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10585-011-9397-5">doi:10.1007/s10585-011-9397-5</ext-link>)<pub-id pub-id-type="pmid">21681495</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gridley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lane</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Garner</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Lienhard</surname><given-names>GE</given-names></name></person-group>
<year>2005</year>
<article-title>Novel insulin-elicited phosphoproteins in adipocytes</article-title>. <source/>Cell. Signal.
<volume>17</volume>, <fpage>59</fpage>–<lpage>66</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cellsig.2004.05.013">doi:10.1016/j.cellsig.2004.05.013</ext-link>)<pub-id pub-id-type="pmid">15451025</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chavez</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Gridley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sano</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lane</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Lienhard</surname><given-names>GE</given-names></name></person-group>
<year>2006</year>
<article-title>The 47 kDa Akt substrate associates with phosphodiesterase 3B and regulates its level in adipocytes</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>342</volume>, <fpage>1218</fpage>–<lpage>1222</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrc.2006.02.091">doi:10.1016/j.bbrc.2006.02.091</ext-link>)<pub-id pub-id-type="pmid">16516160</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Omar</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zmuda-Trzebiatowska</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Manganiello</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Goransson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Degerman</surname><given-names>E</given-names></name></person-group>
<year>2009</year>
<article-title>Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis</article-title>. <source/>Cell. Signal.
<volume>21</volume>, <fpage>760</fpage>–<lpage>766</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cellsig.2009.01.015">doi:10.1016/j.cellsig.2009.01.015</ext-link>)<pub-id pub-id-type="pmid">19167487</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walenta</surname><given-names>E</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>alpha/beta-hydrolase domain containing protein 15 (ABHD15)--an adipogenic protein protecting from apoptosis</article-title>. <source/>PLoS ONE
<volume>8</volume>, <fpage>e79134</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0079134">doi:10.1371/journal.pone.0079134</ext-link>)<pub-id pub-id-type="pmid">24236098</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>ES</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease</article-title>. <source/>Am. J. Respir. Crit. Care Med.
<volume>186</volume>, <fpage>1248</fpage>–<lpage>1255</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1164/rccm.201207-1280OC">doi:10.1164/rccm.201207-1280OC</ext-link>)<pub-id pub-id-type="pmid">23065012</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>DTS</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Conibear</surname><given-names>E</given-names></name></person-group>
<year>2017</year>
<article-title>Targeting the Ras palmitoylation/depalmitoylation cycle in cancer</article-title>. <source/>Biochem. Soc. Trans.
<volume>45</volume>, <fpage>913</fpage>–<lpage>921</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1042/BST20160303">doi:10.1042/BST20160303</ext-link>)<pub-id pub-id-type="pmid">28630138</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Conibear</surname><given-names>E</given-names></name></person-group>
<year>2015</year>
<article-title>ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization</article-title>. <source/>eLife
<volume>4</volume>, <fpage>e11306</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.7554/eLife.11306">doi:10.7554/eLife.11306</ext-link>)<pub-id pub-id-type="pmid">26701913</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tortosa</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Adolfs</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fukata</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pasterkamp</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Kapitein</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Hoogenraad</surname><given-names>CC</given-names></name></person-group>
<year>2017</year>
<article-title>Dynamic palmitoylation targets MAP6 to the axon to promote microtubule stabilization during neuronal polarization</article-title>. <source/>Neuron
<volume>94</volume>, <fpage>809</fpage>–<lpage>825.e807</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuron.2017.04.042">doi:10.1016/j.neuron.2017.04.042</ext-link>)<pub-id pub-id-type="pmid">28521134</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clifford</surname><given-names>RJ</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma</article-title>. <source/>Hepatology
<volume>52</volume>, <fpage>2034</fpage>–<lpage>2043</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hep.23943">doi:10.1002/hep.23943</ext-link>)<pub-id pub-id-type="pmid">21105107</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puig-Oliveras</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ramayo-Caldas</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Corominas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Estelle</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Perez-Montarelo</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hudson</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Casellas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Folch</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Ballester</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>Differences in muscle transcriptome among pigs phenotypically extreme for fatty acid composition</article-title>. <source/>PLoS ONE
<volume>9</volume>, <fpage>e99720</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0099720">doi:10.1371/journal.pone.0099720</ext-link>)<pub-id pub-id-type="pmid">24926690</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name></person-group>
<year>2015</year>
<article-title>ABHD4 regulates multiple classes of N-acyl phospholipids in the mammalian central nervous system</article-title>. <source/>Biochemistry
<volume>54</volume>, <fpage>2539</fpage>–<lpage>2549</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1021/acs.biochem.5b00207">doi:10.1021/acs.biochem.5b00207</ext-link>)<pub-id pub-id-type="pmid">25853435</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vieyres</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Welsch</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gerold</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gentzsch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kahl</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vondran</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Kaderali</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pietschmann</surname><given-names>T</given-names></name></person-group>
<year>2016</year>
<article-title>ABHD5/CGI-58, the chanarin-dorfman syndrome protein, mobilises lipid stores for hepatitis C virus production</article-title>. <source/>PLoS Pathog.
<volume>12</volume>, <fpage>e1005568</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1005568">doi:10.1371/journal.ppat.1005568</ext-link>)<pub-id pub-id-type="pmid">27124600</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukata</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Murakami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yokoi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fukata</surname><given-names>M</given-names></name></person-group>
<year>2016</year>
<article-title>Local palmitoylation cycles and specialized membrane domain organization</article-title>. <source/>Curr. Top. Membr.
<volume>77</volume>, <fpage>97</fpage>–<lpage>141</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/bs.ctm.2015.10.003">doi:10.1016/bs.ctm.2015.10.003</ext-link>)<pub-id pub-id-type="pmid">26781831</pub-id></mixed-citation>
</ref>
<ref id="RSOB180017C105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>BF</given-names></name></person-group>
<year>2009</year>
<article-title>Large-scale profiling of protein palmitoylation in mammalian cells</article-title>. <source/>Nat. Methods
<volume>6</volume>, <fpage>135</fpage>–<lpage>138</lpage>. (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth.1293">doi:10.1038/nmeth.1293</ext-link>)<pub-id pub-id-type="pmid">19137006</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>